CYANVAC LLC
Intranasal PIV5-vectored human metapneumovirus (HMPV) vaccine
- Sector
- Biotech
- Total capital
- $700K
- Federal grants
- $550K
- 3 awards · 2022–2023
- Rank in peer group#1 of 1449
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- $150K
- 1 award · Health and Human S
- Rank in Biotech#307 of 4373
- Granted patents
- 0
- 13 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Developing a PIV5-based human metapneumovirus (HMPV) vaccine$250K
- Federal grantHealth and Human S · Phase I · Developing a liquid formulation for CVXGA1 COVID-19 intranasal vaccine$150K
- Federal contractHealth and Human S · SBIR Phase I Igf::ot::igf$150K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
1 record has no date or no amount, so it isn’t placed on the timeline.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Federal grants#1 · top 1%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 0 granted of 13- PendingModified PIV5 Vaccine Vectors: Methods Of Making And UsesUSPTOApplication 18433149
- PendingPIV5-BASED Coronavirus Vaccines And Methods Of Use ThereofUSPTOApplication 17933812
- PendingModified PIV5 Vaccine Vectors: Methods Of Making And UsesUSPTOApplication PCTUS2024014505
Show all 13 patent records
- Modified PIV5 Vaccine Vectors: Methods Of Making And UsesAug 29, 2024 · Application 18433149Pending
- PIV5-BASED Coronavirus Vaccines And Methods Of Use ThereofApr 6, 2023 · Application 17933812Pending
- Modified PIV5 Vaccine Vectors: Methods Of Making And UsesApplication PCTUS2024014505Pending
- Formulation Providing Increased Stability For Vaccines CompositionApplication 63617736Pending
- PIV5-BASED Vaccines With Modified Antigen: Methods Of Making And Using The SameApplication 63588633Pending
- Modified PIV5 Vaccine Vectors: Methods Of Making And UsesApplication 63483377Pending
- Rsv Recombinant Vaccine: Methods Of Making And Using The SameApplication 63382453Pending
- PIV5-BASED Coronavirus Vaccines And Methods Of Use ThereofApplication PCTUS2022076732Pending
- Intranasal Parainfluenza Virus 5 (PIV5)-BASED COVID-19 Vaccine CVXGA1 Protects Hamsters Against Sars-cov 2 Variants InfectionApplication 63365934Pending
- PIV5-BASED Vaccines With Modified Antigen: Methods Of Making And Using The SameApplication 19526269Pending
- Improved Formulation Providing Increased Stability For Vaccines CompositionApplication PCTUS2025010273Pending
- Improved Formulation Providing Increased Stability For Vaccines CompositionApplication 19603322Pending
- PIV5-BASED Vaccines With Modified Antigen: Methods Of Making And Using The SameApplication PCTUS2024050117Pending
Related companies, and why
- Scale BiosciencesSimilar federal contract value in Biotech · $151K in contracts
- AMERICAN GENE TECHNOLOGIES INTERNATIONALSimilar federal contract value in Biotech · $150K in contracts
- ALPHATHERASimilar federal contract value in Biotech · $150K in contracts
- EVAS THERAPEUTICS LLCSimilar federal contract value in Biotech · $150K in contracts
- RESPIRERX PHARMACEUTICALS INC.Similar federal contract value in Biotech · $149K in contracts
- PROTEIN METRICS INCSimilar federal contract value in Biotech · $147K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .